Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Pathogenesis and treatment of malnutrition in maintenance dialysis

Marsha Wolfson, MD, FACP
Section Editor
Steve J Schwab, MD
Deputy Editor
Alice M Sheridan, MD


Malnutrition is an important problem in patients treated with chronic hemodialysis or peritoneal dialysis. It occurs in 20 to 70 percent of patients (depending upon the method used to measure nutritional status), with an increasing length of time on dialysis correlating with an increasing decline in nutritional parameters [1-3].

There may be significant differences between countries with respect to some measures of nutritional status, such as serum albumin concentration [4]. Based upon the Dialysis Outcomes and Practice Patterns Study (DOPPS), for example, the following mean serum albumin levels were reported in France (3.87 mg/dL), Germany (4.17 mg/dL), Italy (3.98 mg/dL), Spain (3.98 mg/dL), the United States (3.6 mg/dL), and the United Kingdom (3.72 mg/dL) [4]. However, since differences in measurement methods cause differences in results, the method used from laboratory to laboratory and country to country must be known to assess any true differences in serum albumin in an individual patient or groups of patients.

Two important issues are discussed elsewhere:

How is nutritional status evaluated? (See "Assessment of nutritional status in dialysis patients".)

What is the relation between nutritional status and survival? Patients with malnutrition, as manifested in part by hypoalbuminemia, measured at the onset of or during maintenance dialysis, have an increased mortality rate (figure 1A-B). This is true for patients treated with either maintenance hemodialysis or peritoneal dialysis [5-8]. (See "Patient survival and maintenance dialysis".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Feb 20 00:00:00 GMT+00:00 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Chertow GM, Johansen KL, Lew N, et al. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 2000; 57:1176.
  2. Rocco MV, Paranandi L, Burrowes JD, et al. Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis 2002; 39:245.
  3. Centers for Medicare and Medicaid Services, Kinney R. 2005 Annual Report: ESRD Clinical Performance Measures Project. Am J Kidney Dis 2006; 48:S1.
  4. Combe C, McCullough KP, Asano Y, et al. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis 2004; 44:39.
  5. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15:458.
  6. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7:198.
  7. Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62:2238.
  8. Port FK, Pisoni RL, Bragg-Gresham JL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif 2004; 22:175.
  9. Lindsay RM, Spanner E, Heidenheim RP, et al. Which comes first, Kt/V or PCR--chicken or egg? Kidney Int Suppl 1992; 38:S32.
  10. Lindsay RM, Nesrallah G, Suri R, et al. Is more frequent hemodialysis beneficial and what is the evidence? Curr Opin Nephrol Hypertens 2004; 13:631.
  11. Davies SJ, Phillips L, Griffiths AM, et al. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int 2000; 57:1743.
  12. Mitch WE, Maroni BJ. Factors causing malnutrition in patients with chronic uremia. Am J Kidney Dis 1999; 33:176.
  13. Riella MC. Malnutrition in dialysis: malnourishment or uremic inflammatory response? Kidney Int 2000; 57:1211.
  14. Chazot C, Laurent G, Charra B, et al. Malnutrition in long-term haemodialysis survivors. Nephrol Dial Transplant 2001; 16:61.
  15. Bossola M, Muscaritoli M, Tazza L, et al. Malnutrition in hemodialysis patients: what therapy? Am J Kidney Dis 2005; 46:371.
  16. Bossola M, Tazza L, Giungi S, Luciani G. Anorexia in hemodialysis patients: an update. Kidney Int 2006; 70:417.
  17. Blumenkrantz MJ, Gahl GM, Kopple JD, et al. Protein losses during peritoneal dialysis. Kidney Int 1981; 19:593.
  18. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994; 46:830.
  19. Kaplan AA, Halley SE, Lapkin RA, Graeber CW. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995; 47:573.
  20. Sherman RA, Cody RP, Rogers ME, Solanchick JC. Interdialytic weight gain and nutritional parameters in chronic hemodialysis patients. Am J Kidney Dis 1995; 25:579.
  21. Lim VS, Ikizler TA, Raj DS, Flanigan MJ. Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics. J Am Soc Nephrol 2005; 16:862.
  22. Gutierrez A, Alvestrand A, Wahren J, Bergström J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38:487.
  23. Uribarri J, Levin NW, Delmez J, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis 1999; 34:493.
  24. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335:1897.
  25. Pickering WP, Price SR, Bircher G, et al. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 2002; 61:1286.
  26. Mamoun AH. Anorexia in patients with chronic renal failure--progress towards understanding the molecular basis. Nephrol Dial Transplant 1998; 13:2460.
  27. Daschner M, Tönshoff B, Blum WF, et al. Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 1998; 9:1074.
  28. Johansen KL, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 1998; 9:1080.
  29. Fouque D, Juillard L, Lasne Y, et al. Acute leptin regulation in end-stage renal failure: the role of growth hormone and IGF-1. Kidney Int 1998; 54:932.
  30. Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis 2005; 45:891.
  31. Jones CH, Wells L, Stoves J, et al. Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 2002; 39:872.
  32. Dumler F. Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. ASAIO J 2003; 49:282.
  33. Misra M, Nolph KD, Khanna R, et al. Retrospective evaluation of renal kt/V(urea) at the initiation of long-term peritoneal dialysis at the University of Missouri: relationships to longitudinal nutritional status on peritoneal dialysis. ASAIO J 2003; 49:91.
  34. Cano N, Labastie-Coeyrehourq J, Lacombe P, et al. Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 1990; 52:726.
  35. Ohkawa S, Kaizu Y, Odamaki M, et al. Optimum dietary protein requirement in nondiabetic maintenance hemodialysis patients. Am J Kidney Dis 2004; 43:454.
  36. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35:S1.
  37. Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant 2007; 22 Suppl 2:ii5.
  38. Veeneman JM, Kingma HA, Boer TS, et al. The metabolic response to ingested protein is normal in long-term hemodialysis patients. Am J Kidney Dis 2004; 43:330.
  39. Slomowitz LA, Monteon FJ, Grosvenor M, et al. Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 1989; 35:704.
  40. Rothstein RD, Alavi A. The evaluation of the patient with gastroparesis secondary to insulin-dependent diabetes mellitus. J Nucl Med 1992; 33:1707.
  41. Grodstein G, Harrison A, Roberts C, et al. Impaired gastric emptying in hemodialysis patients (abstract). Kidney Int 1979; 16:952.
  42. De Schoenmakere G, Vanholder R, Rottey S, et al. Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant 2001; 16:1850.
  43. Bateman DN, Gokal R, Dodd TR, Blain PG. The pharmacokinetics of single doses of metoclopramide in renal failure. Eur J Clin Pharmacol 1981; 19:437.
  44. Tack J, Janssens J, Vantrappen G, et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992; 103:72.
  45. Silang R, Regalado M, Cheng TH, Wesson DE. Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying. Am J Kidney Dis 2001; 37:287.
  46. Brown CK, Khanderia U. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Clin Pharm 1990; 9:357.
  47. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996; 335:290.
  48. Ross EA, Koo LC. Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. Am J Kidney Dis 1998; 31:62.
  49. Kopple JD. Therapeutic approaches to malnutrition in chronic dialysis patients: the different modalities of nutritional support. Am J Kidney Dis 1999; 33:180.
  50. Caglar K, Fedje L, Dimmitt R, et al. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 2002; 62:1054.
  51. Stratton RJ, Bircher G, Fouque D, et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis 2005; 46:387.
  52. Lacson E Jr, Wang W, Zebrowski B, et al. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis 2012; 60:591.
  53. Wright S, Weiner DE. Oral nutritional supplement use in dialysis patients: full speed ahead? Am J Kidney Dis 2012; 60:507.
  54. Weiner DE, Tighiouart H, Ladik V, et al. Oral intradialytic nutritional supplement use and mortality in hemodialysis patients. Am J Kidney Dis 2014; 63:276.
  55. Cheu C, Pearson J, Dahlerus C, et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol 2013; 8:100.
  56. Eustace JA, Coresh J, Kutchey C, et al. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. Kidney Int 2000; 57:2527.
  57. Abras E, Walser M. Nitrogen utilization in uremic patients fed by continuous nasogastric infusion. Kidney Int 1982; 22:392.
  58. Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982; 21:500.
  59. McCann L, Feldman C, Hornberger J, et al. Effect of intradialytic parenteral nutrition on delivered Kt/V. Am J Kidney Dis 1999; 33:1131.
  60. Pupim LB, Flakoll PJ, Brouillette JR, et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002; 110:483.
  61. Foulks CJ. An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 1999; 33:186.
  62. Capelli JP, Kushner H, Camiscioli TC, et al. Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 1994; 23:808.
  63. Wolfson M. Use of intradialytic parenteral nutrition in hemodialysis patients. Am J Kidney Dis 1994; 23:856.
  64. Cano NJ, Fouque D, Roth H, et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 2007; 18:2583.
  65. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010.
  66. Rocco MV, Dwyer JT, Larive B, et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65:2321.
  67. Jager KJ, Merkus MP, Huisman RM, et al. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001; 12:1272.
  68. Ziegler TR, Lazarus JM, Young LS, et al. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991; 2:1130.
  69. Ikizler TA, Wingard RL, Breyer JA, et al. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 1994; 46:1178.
  70. Johannsson G, Bengtsson BA, Ahlmén J. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. Am J Kidney Dis 1999; 33:709.
  71. Feldt-Rasmussen B, Lange M, Sulowicz W, et al. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol 2007; 18:2161.
  72. Ikizler TA, Wingard RL, Flakoll PJ, et al. Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients. Kidney Int 1996; 50:229.
  73. Garibotto G, Barreca A, Russo R, et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997; 99:97.
  74. Iglesias P, Díez JJ, Fernández-Reyes MJ, et al. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am J Kidney Dis 1998; 32:454.
  75. Ikizler TA, Wingard RL, Hakim RM. Interventions to treat malnutrition in dialysis patients: the role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 1995; 26:256.
  76. Fouque D, Peng SC, Shamir E, Kopple JD. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 2000; 57:646.
  77. Hansen TB, Gram J, Jensen PB, et al. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol 2000; 53:99.
  78. Garibotto G, Barreca A, Sofia A, et al. Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition. J Am Soc Nephrol 2000; 11:2106.
  79. Kotzmann H, Schmidt A, Lercher P, et al. One-year growth hormone therapy improves granulocyte function without major effects on nutritional and anthropometric parameters in malnourished hemodialysis patients. Nephron Clin Pract 2003; 93:C75.
  80. Kopple JD, Cheung AK, Christiansen JS, et al. OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3:1741.
  81. Gascón A, Belvis JJ, Berisa F, et al. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Geriatr Nephrol Urol 1999; 9:67.
  82. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 1999; 281:1275.
  83. Barton Pai A, Chretien C, Lau AH. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients. Clin Nephrol 2002; 58:38.
  84. Atkin-Thor E, Goddard BW, O'Nion J, et al. Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 1978; 31:1948.
  85. Burge JC, Park HS, Whitlock CP, Schemmel RA. Taste acuity in patients undergoing long-term hemodialysis. Kidney Int 1979; 15:49.
  86. Hylander B, Barkeling B, Rössner S. Eating behavior in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1992; 20:592.
  87. Bouma SF, Dwyer JT. Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis. J Am Diet Assoc 1984; 84:194.
  88. Aguirre Galindo BA, Prieto Fierro JG, Cano P, et al. Effect of polymeric diets in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2003; 23:434.
  89. González-Espinoza L, Gutiérrez-Chávez J, del Campo FM, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2005; 25:173.
  90. Teixidó-Planas J, Ortiz A, Coronel F, et al. Oral protein-energy supplements in peritoneal dialysis: a multicenter study. Perit Dial Int 2005; 25:163.
  91. Boudville N. Oral nutritional supplementation in peritoneal dialysis patients--does it work? Perit Dial Int 2005; 25:157.
  92. Bruno M, Bagnis C, Marangella M, et al. CAPD with an amino acid dialysis solution: a long-term, cross-over study. Kidney Int 1989; 35:1189.
  93. Kopple JD, Bernard D, Messana J, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47:1148.
  94. Jones M, Hagen T, Boyle CA, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis 1998; 32:761.
  95. Wolfson M, Jones M. Intraperitoneal nutrition. Am J Kidney Dis 1999; 33:203.
  96. Qamar IU, Secker D, Levin L, et al. Effects of amino acid dialysis compared to dextrose dialysis in children on continuous cycling peritoneal dialysis. Perit Dial Int 1999; 19:237.
  97. Tjiong HL, van den Berg JW, Wattimena JL, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 2005; 16:1486.
  98. Dombros N, Dratwa M, Feriani M, et al. European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. Nephrol Dial Transplant 2005; 20 Suppl 9:ix3.
  99. Ramage IJ, Geary DF, Harvey E, et al. Efficacy of gastrostomy feeding in infants and older children receiving chronic peritoneal dialysis. Perit Dial Int 1999; 19:231.
  100. Stein A, Moorhouse J, Iles-Smith H, et al. Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 1997; 52:1089.
  101. Goodship TH. What is the relationship between metabolic acidosis and nutritional status in dialysis patients? Am J Kidney Dis 1998; 31:884.
  102. Wynne K, Giannitsopoulou K, Small CJ, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005; 16:2111.